series-c-plus
Stage
1
Investors
About
Galera Therapeutics, Inc. is a clinical-stage biotechnology company developing novel therapeutics to improve anti-cancer efficacy and reduce the side effects of cancer treatments, particularly for breast cancer patients.
Explore Galera Therapeutics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.